Intensity-Modulated Radiation Therapy, Pemetrexed, and Erlotinib in Treating Patients With Recurrent or Second Primary Head and Neck Cancer
Clinical trial NCT00573989 · TERMINATED
Trial details
- NCT number
- NCT00573989
- Sponsor
- Wake Forest University Health Sciences
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-03-01
- Primary completion
- 2017-03-01
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.